Vitamin C is one of the largest vitamin varieties in the world in terms of production and sales. Its manufacturers are mainly concentrated in China. The barriers to entry in the industry are low, and there are many manufacturers. The main companies in the industry include CSPC, Luwei Pharmaceutical, DSM Jiangshan, Northeast Pharmaceutical, Tianli Pharmaceutical, Qiyuan Pharmaceutical, Zhengzhou Tuoyang, etc. At present, the global demand for vitamin C exceeds 200,000 tons, and China's supply accounts for about 70%. It is the global vitamin C production base.
Analysis of the price of vitamin C in the past four years, the price in 2018 was at a high position, and the price fluctuated greatly throughout the year, showing a trend of high opening and low decline.
At the beginning of the year, the price was as high as 70, and at the end of the year, the price dropped to 30, a drop of 133%.
The price has been low in 2019 and 2020, and the market is stable between 20-30 throughout 2019, with occasional fluctuations. At the beginning of the new year in 2022, the price has a downward trend. At present, the price has fallen below 40, and the actual transaction price is around 35, which has dropped significantly compared with the same period last year. Although high prices have brought huge profits to production enterprises, cost pressures have increased for downstream enterprises.